Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBIT Margin: 2016-2018

Historic EBIT Margin for ENDRA Life Sciences (NDRA) over the last 2 years, with Mar 2018 value amounting to -45,960.77%.

  • ENDRA Life Sciences' EBIT Margin was N/A to -45,960.77% in Q1 2018 from the same period last year, while for Mar 2018 it was -1,984.92%, marking a year-over-year change of. This contributed to the annual value of -9,971.19% for FY2024, which is 768648.00% down from last year.
  • As of Q1 2018, ENDRA Life Sciences' EBIT Margin stood at -45,960.77%, which was down 37.09% from -33,526.58% recorded in Q4 2017.
  • In the past 5 years, ENDRA Life Sciences' EBIT Margin ranged from a high of 249,652.53% in Q2 2016 and a low of -45,960.77% during Q1 2018.
  • Its 3-year average for EBIT Margin is 24,016.98%, with a median of -317.40% in 2017.
  • Data for ENDRA Life Sciences' EBIT Margin shows a maximum YoY plummeted of 25,148,188bps (in 2017) over the last 5 years.
  • ENDRA Life Sciences' EBIT Margin (Quarterly) stood at -61.85% in 2016, then slumped by 3,346,474bps to -33,526.58% in 2017, then reached -45,960.77% in 2018.
  • Its last three reported values are -45,960.77% in Q1 2018, -33,526.58% for Q4 2017, and -317.40% during Q3 2017.